Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Jul 17, 2026
Roblox (RBLX) Shares Advance +12.5% as Metrics Stabilize and New AI Tool Debuts

Roblox (RBLX) Shares Advance +12.5% as Metrics Stabilize and New AI Tool Debuts

Key Takeaways

  • Roblox (RBLX) shares climbed approximately 12.5% over the last 30 days, rising from $48.02 on June 17, 2026, to $54.01 at the close on July 16, 2026.
  • The rally was fueled by stabilizing user metrics following the global rollout of Kids and Select accounts, easing investor concerns about age-verification headwinds.
  • The July 16 announcement of "Build" — a new mobile-first AI creation tool that turns text prompts into playable games — reinforced the company's AI-driven growth narrative.
  • Analyst sentiment improved, with Wells Fargo raising its price target to $56 (Overweight) and Raymond James noting minimal disruption from the new account structure.
  • Despite the 30-day gains, the stock remains down approximately 32% year-to-date, weighed by the April guidance cut that slashed 2026 bookings growth expectations from roughly 24% to about 10%.

Roblox (RBLX) Company Overview and Market Position

Roblox Corporation operates one of the world's largest immersive gaming and creation platforms, connecting millions of users through user-generated experiences. The platform consists of the Roblox Client — available on iOS, Android, Windows, Mac, Xbox, PlayStation, and VR hardware — along with Roblox Studio, a free development toolset that lets creators build and publish games, and Roblox Cloud, the underlying infrastructure. Roblox's business model is built on a virtual economy where users purchase the platform's currency, Robux, to access in-experience items and upgrades, generating revenue that is shared with creators. With over 130 million daily active users globally and support for 17 languages, RBLX occupies a distinctive position at the intersection of social media, gaming, and user-generated content — a space where Meta, EA, and U also compete. Investors track RBLX closely for its bookings growth, DAU trends, hours engaged, and monetization metrics as key indicators of platform health and long-term expansion potential. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Roblox (RBLX) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, RBLX shares gained approximately 12.5%, moving from a close of $48.02 on June 17, 2026, to $54.01 on July 16, 2026. The advance was not linear: the stock surged to an intra-period high of $57.95 on July 1 before pulling back amid broader market fluctuations and lingering uncertainty around second-quarter bookings. The 30-day rally reflects a sharp reversal of sentiment after the stock bottomed near $41.82 in early June. Over the broader quarter, RBLX has staged a recovery from its post-earnings trough: the stock plunged 18% on April 30 after the company reported Q1 2026 results and drastically lowered its full-year bookings guidance, falling to the $45 range. The subsequent three-month climb back above $54 — a gain of roughly 20% from those lows — highlights a market gradually regaining confidence as user metrics showed signs of stabilization and new product initiatives emerged. However, shares remain well below their 2025 highs above $130.

What Drove RBLX Stock Price in the Last 30 Days

Several catalysts converged to drive RBLX shares higher during the 30-day period. The global rollout of Kids and Select accounts on June 16 marked a pivotal moment: the new tiered account system, which assigns users ages 5-8 to Kids accounts and ages 9-15 to Select accounts based on facial age verification, was widely viewed as a test of management credibility following the April guidance cut. Four weeks into the rollout, Raymond James reported that tracked data showed little disruption to recent usage trends, with mobile time spent declining only in low single-digits year-over-year — consistent with pre-rollout patterns. This stabilizing data helped ease fears that age verification would cause sustained user attrition.

On July 16, Roblox unveiled "Build," a mobile-first creation tab enabling users to turn text prompts into basic playable games directly within the Roblox app, powered by a suite of AI models handling gameplay mechanics, environments, characters, and sound. The announcement signaled an aggressive push into AI-powered creation tools, including upcoming agentic features for playtesting, analytics, and experimentation. Wells Fargo also raised its price target to $56 while maintaining an Overweight rating, and Citi reaffirmed its Buy rating with a $70 target ahead of the upcoming Q2 earnings report. These analyst actions, combined with the product launch, reinforced the narrative that Roblox is managing the age-verification transition while advancing its platform technology. One thing that stands out is how these developments appear to be supporting the current price action.

What Drove RBLX Stock Performance Over the Last Quarter

The last quarter was defined by a sharp correction followed by a methodical recovery. On April 30, Roblox released Q1 2026 results revealing that daily active users had declined sequentially across all regions — including a nearly 20% drop in Europe — and that only 51% of global DAUs had completed age verification. Management slashed full-year bookings growth guidance from approximately 24% to just 8-12%, triggering an 18% single-day selloff to around $45. The guidance revision reflected the unanticipated severity of friction caused by mandatory age checks, including reduced app store ratings and weaker organic sign-ups. Morningstar subsequently cut its fair value estimate from $67 to $55, and TD Cowen downgraded the stock to Hold in early May.

Since then, the recovery narrative has been built on three pillars: first, data showing that user engagement and monetization metrics were stabilizing rather than deteriorating further; second, the successful execution of the Kids and Select account launch with limited incremental disruption; and third, a series of product announcements — including Procedural Models, the Cube 3D foundation model, and the Build creation suite — that reinforced Roblox's AI ambitions. The stock's climb from the low $40s back above $54 reflects cautious optimism that the worst of the age-verification transition may be priced in, even as uncertainty around DAU trajectory and legal risks persists. From what I see, this measured rebound warrants close attention.

Using Tickeron’s Trending AI Robots for Additional Context

In my research process, I often review Tickeron’s Trending AI Robots page to gain a data-driven perspective on how automated strategies are performing across various assets. While Tickeron hosts hundreds of bots trading thousands of tickers across equities, ETFs, and forex, only those demonstrating the strongest recent performance and relevance appear in this featured section. The bots span a wide range of strategies — from swing trading and trend following to pattern recognition and momentum-based approaches — across multiple timeframes and risk profiles. Each bot is independently rated on key performance metrics including win rate, trade frequency, and drawdown, enabling users to evaluate bots that align with their trading style. For investors tracking stocks like RBLX, the Trending AI Robots section provides a useful complement to fundamental analysis.

RBLX Stock Forecast Drivers: What Investors Should Watch Next

RBLX is scheduled to report Q2 2026 earnings on July 30, and the release will be the single most important near-term catalyst. Citi expects Q2 bookings near the low end of the $1.55 billion to $1.61 billion guidance range, while consensus revenue estimates stand at approximately $1.59 billion. Investors will scrutinize DAU trends, hours engaged, monthly unique payer metrics, and any updates to full-year guidance. Key forward-looking factors include the pace of age-verification completion among the remaining global user base, the adoption trajectory of Build and other AI-powered creation tools, developer economics and DevEx payout dynamics, and competitive pressures from platforms like Meta's Pocket. The ongoing securities class action — with a lead plaintiff deadline of August 7, 2026 — adds legal overhang. Macroeconomic conditions, including consumer discretionary spending trends and interest rate policy, also remain relevant given Roblox's reliance on user monetization. While the 30-day rally signals improving sentiment, the path forward hinges on whether Roblox can demonstrate sustained DAU recovery and bookings growth that validates management's long-term strategy. I’m watching this closely ahead of the earnings release.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RBLX

RBLX's Indicator enters downward trend

The Aroon Indicator for RBLX entered a downward trend on August 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 199 similar instances where the Aroon Indicator formed such a pattern. In of the 199 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RBLX as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RBLX turned negative on July 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

RBLX moved below its 50-day moving average on July 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RBLX crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RBLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RBLX advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

RBLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RBLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RBLX's P/B Ratio (169.492) is very high in comparison to the industry average of (11.438). P/E Ratio (0.000) is within average values for comparable stocks, (17.535). RBLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.052). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. RBLX's P/S Ratio (4.509) is slightly higher than the industry average of (2.023).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RBLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are NetEase (NASDAQ:NTES), Electronic Arts (NASDAQ:EA), Take-Two Interactive Software (NASDAQ:TTWO).

Industry description

TVs, telephones, washing machines, home speakers and even home-office equipment like computers and printers…the list is virtually endless when it comes to consumer electronics and appliances. And, with ‘smarthomes’ increasingly becoming the reality, we could see a sharp surge in high-tech gadgets (including robotic appliances) making their way into our homes– and therefore spelling plenty opportunities in the related industries. Consumers account for 70% of US GDP, and their purchases of high-functioning electronics could make significant dents in the economy’s health. Sony Corp., Whirlpool and iRobot are some of the major consumer electronics/appliances makers.

Market Cap

The average market capitalization across the Electronics/Appliances Industry is 10.08B. The market cap for tickers in the group ranges from 78.65K to 403.7B. SSNLF holds the highest valuation in this group at 403.7B. The lowest valued company is BHAT at 78.65K.

High and low price notable news

The average weekly price growth across all stocks in the Electronics/Appliances Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 4%. SNAL experienced the highest price growth at 17%, while PLTK experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Electronics/Appliances Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 333% and the average quarterly volume growth was 134%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 66
Price Growth Rating: 57
SMR Rating: 76
Profit Risk Rating: 93
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
RBLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ElectronicsAppliances

Profile
Details
Industry
N/A
Address
970 Park Place
Phone
+1 888 858-2569
Employees
2457
Web
https://www.corp.roblox.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.